Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05622344 · ClinicalTrials.gov registry record · NA
StableEyes With Active Neurofeedback
A NA study of Vestibular Schwannoma and Vestibular Disorder, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 2
- Study locations
NCT05622344 is a NA study of Vestibular Schwannoma and Vestibular Disorder that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 48 participants, roughly in line with the 46-participant average among 7 other Vestibular Schwannoma trials with a reported enrollment target. The trial reports 2 study locations across 2 states.
The verdict
NCT05622344, a NA study of Vestibular Schwannoma and Vestibular Disorder, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.
Conditions Studied
Interventions
- BEHAVIORAL Traditional Therapy
- DEVICE SWAN
Study Locations (2)
Maryland
- Johns Hopkins University - Baltimore
Ohio
- Naval Medical Research Unit - Dayton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2022-08-08 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05622344
The ClinicalTrials.gov registry entry for NCT05622344 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 46-participant average among 7 other Vestibular Schwannoma trials with a reported enrollment target. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Vestibular Schwannoma appearing as the primary indexed condition, and to 2 interventions - of which Traditional Therapy is the first listed.
NCT05622344 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Ohio.
Frequently Asked Questions
What is clinical trial NCT05622344 about?
NCT05622344 is a clinical study titled "StableEyes With Active Neurofeedback". The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.
What is the current status of trial NCT05622344?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2022-08-08. Estimated completion is 2026-09-30.
What conditions does trial NCT05622344 study?
This clinical trial studies the following conditions: Vestibular Schwannoma, Vestibular Disorder, Motion Sickness, Space Motion Sickness.
What interventions are being tested in trial NCT05622344?
The interventions under investigation include: Traditional Therapy (BEHAVIORAL), SWAN (DEVICE).
Who is sponsoring clinical trial NCT05622344?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05622344 being conducted?
This trial has 2 study locations across Maryland, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vestibular Schwannoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CI Following VS Removal or Labyrinthectomy
RECRUITING · NA
-
Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients with Vestibular Schwannomas
RECRUITING · NA
-
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
RECRUITING · Phase 1
-
Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
ACTIVE NOT RECRUITING · Phase 2
-
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
ACTIVE NOT RECRUITING · Phase 2
-
Study of Aspirin in Patients With Vestibular Schwannoma
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.